← Back to Search

Reinforcement learning message delivery for COVID-19

N/A
Waitlist Available
Led By Adrian Aguilera, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over 18 years old
Own a mobile phone
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is testing whether text messages can help improve symptoms of depression and anxiety, as well as enhance positive mood, in people coping with the stress of social distancing due to COVID-19.

Eligible Conditions
  • COVID-19
  • Anxiety
  • Coronavirus
  • Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety scores
Depression scores
Secondary outcome measures
Self reported mood ratings

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Reinforcement LearningExperimental Treatment1 Intervention
In this arm we will test a reinforcement learning (RL) algorithm with a learned decision mechanism for the timing and type of text-messages. The algorithm learns from previous data (which messages were sent, what was the participants' mood) to maximize an increase in participants' mood.
Group II: Uniform RandomActive Control1 Intervention
Participants will receive supportive text-messages for a period of 2 months. These text-messages have two categories: behavioral activation (BA) and coping skills. In this arm, participants will receive one of these types of messages daily on a random schedule in random time periods throughout the day.
Group III: Mood ratings onlyActive Control1 Intervention
In this arm, participants will monitor their mood and receive random feedback based on mood responses.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reinforcement learning message delivery
2020
N/A
~1110

Find a Location

Who is running the clinical trial?

University of California, BerkeleyLead Sponsor
177 Previous Clinical Trials
719,924 Total Patients Enrolled
3 Trials studying COVID-19
118,988 Patients Enrolled for COVID-19
Adrian Aguilera, PhDPrincipal InvestigatorUC Berkeley
3 Previous Clinical Trials
755 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor still have room for new participants?

"Unfortunately, the data on clinicaltrials.gov reveals that this research study is not currently enrolling individuals. Initially posted on April 17th 2020 and last revised August 19th 2022, it stands in stark contrast to the 2,347 other trials actively seeking patients right now."

Answered by AI
Recent research and studies
~203 spots leftby Mar 2025